Unresectable Laryngeal Neoplasms
Showing 1 - 25 of 6,345
Laryngeal Tumors Trial in Guangzhou (Irreversible electroporation (IRE), NanoKnife)
Completed
- Laryngeal Neoplasms
- Irreversible electroporation (IRE)
- NanoKnife
-
Guangzhou, Guangdong, ChinaBiological treatment center in Fuda cancer hospital
Sep 1, 2021
Laryngeal Cancer, Hypopharyngeal Cancer Trial in Shanghai (Toripalimab)
Recruiting
- Laryngeal Cancer
- Hypopharyngeal Cancer
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jun 12, 2022
Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced Hypopharyngeal Squamous Cell Carcinoma, Locally
Recruiting
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- +18 more
- Proton Beam Radiation Therapy
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 30, 2021
Larynx Cancer, Hypopharyngeal Cancer Trial in Shanghai (procedure, radiation, drug)
Recruiting
- Larynx Cancer
- Hypopharyngeal Cancer
- Surgery
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Sep 9, 2023
The Voice asTool to Detect Recurrence of Laryngeal and
Not yet recruiting
- Laryngeal Cancer
- Hypopharyngeal Cancer
- Voice recording, ENT (Ear, Nose and Throat) examination including transnasal fiberendoscopy, and VHI-30-questionnaire
-
Bern, SwitzerlandDepartment of Oto-Rhino-Laryngology, Head and Neck Surgery, Inse
May 30, 2023
Workshops and Exchange Groups for Laryngectomized Patients
Not yet recruiting
- Laryngectomy; Status
- Laryngeal Cancer
-
Paris, FranceBichat - Claude Bernard Hospital
Oct 5, 2023
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Recruiting
- Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +26 more
- Biopsy
- +5 more
-
Newark, Delaware
- +52 more
Feb 2, 2023
Laryngeal Cancer, Hypopharynx Cancer, Laryngeal Tumors Trial in Shanghai (chemo TP regimen combined with Toripalimab)
Recruiting
- Laryngeal Cancer
- +2 more
- chemotherapy TP regimen combined with Toripalimab
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jan 2, 2022
Surgically Treated Patients With Laryngeal Cancer
Recruiting
- Oxidative Stress Induction
- +5 more
- Analgesics, Opioid
- Analgesics, Non-Narcotic
-
Belgrade, Serbia
- +1 more
May 10, 2023
Larynx Cancer Stage I, Glottic Carcinoma Trial in Cairo (Hypofractionated single vocal cord irradiation, Whole laryngeal
Recruiting
- Larynx Cancer Stage I
- Glottic Carcinoma
- Hypofractionated single vocal cord irradiation
- Whole laryngeal radiotherapy
-
Cairo, EgyptNational Cancer Institute, Cairo University
Jan 10, 2023
Laryngeal Cancer Stage II, Laryngeal Cancer Stage III, Carcinoma, Squamous Cell Trial in Amsterdam (radiotherapy, Olaparib)
Active, not recruiting
- Laryngeal Cancer Stage II
- +3 more
- radiotherapy
- Olaparib
-
Amsterdam, NetherlandsThe Netherlands Cancer Institute
Sep 27, 2022
Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Stage III
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
- +11 more
- KEYTRUDA®
- (no location specified)
Nov 17, 2023
Laryngeal Cancer, Dysphagia Trial in Guangzhou (Open partial horizontal laryngectomy(OPHL), Type I-III, Transoral endoscopic
Recruiting
- Laryngeal Cancer
- Dysphagia
- Open partial horizontal laryngectomy(OPHL), Type I-III
- Transoral endoscopic laser cordectomy
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's hospital
Sep 8, 2023
Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Hypopharynx Trial in Rotterdam (CRGD-ZW800-1)
Not yet recruiting
- Squamous Cell Carcinoma of the Larynx
- Squamous Cell Carcinoma of the Hypopharynx
-
Rotterdam, Zuid-Holland, NetherlandsErasmus Medical Center
Feb 21, 2023
Unresectable Pancreatic Cancer, Unresectable Bile Duct Carcinoma, Unresectable Biliary Tract Carcinoma Trial (Tripegfilgrastim)
Not yet recruiting
- Unresectable Pancreatic Cancer
- +2 more
- (no location specified)
Nov 13, 2023
Colon Cancer Liver Metastases Trial (sequential adult left lateral lobe liver transplantation (SALT))
Not yet recruiting
- Colon Cancer Liver Metastases
- sequential adult left lateral lobe liver transplantation (SALT)
- (no location specified)
Oct 3, 2023
Unresectable or Metastatic Colorectal Cancer Trial in Shenyang (FOLFOX/FOLFIRI)
Recruiting
- Unresectable or Metastatic Colorectal Cancer
-
Shenyang, Liaoning, ChinaLiaoning Cancer Hospital & Institute
Mar 22, 2023
Unresectable/Metastatic Colorectal Cancer Trial in Guangzhou (Fruquintinib plus camrelizumab and capecitabine)
Recruiting
- Unresectable/Metastatic Colorectal Cancer
- Fruquintinib plus camrelizumab and capecitabine
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 19, 2023
Secondary Malignant Tumor of Retroperitoneum, Secondary Malignant Tumor of Peritoneum, Pseudomyxoma Peritonei Trial in Cleveland
Not yet recruiting
- Secondary Malignant Neoplasm of Retroperitoneum
- +2 more
- Intestinal, Multivisceral or Modified Multivisceral Transplantation
- +3 more
-
Cleveland, OhioCleveland Clinic Digestive Disease & Surgery Institute (DDSI), C
Oct 10, 2023
Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as
Completed
- Colorectal Cancer Metastatic
- Targeted agent
- (no location specified)
Aug 31, 2023
Pancreatic Tumors Trial in Shanghai (Utidelone injection in combination with gemcitabine)
Recruiting
- Pancreatic Neoplasms
- Utidelone injection in combination with gemcitabine
-
Shanghai, Shanghai, ChinaShanghai First People's Hospital
Mar 21, 2023
Unresectable Colorectal Liver Metastases Trial in Nanjing (Selective internal radiation therapy (SIRT) with yttrium-90 carbon
Recruiting
- Unresectable Colorectal Liver Metastases
- Selective internal radiation therapy (SIRT) with yttrium-90 carbon microspheres
-
Nanjing, Jiangsu, ChinaZhongda Hospital Southeast University
Jan 26, 2023
Unresectable Pancreatic Cancer Trial (creon 35.000 Ph.U (R), Best Standarard of Care)
Not yet recruiting
- Unresectable Pancreatic Cancer
- creon 35.000 Ph.U (R)
- Best Standarard of Care
- (no location specified)
Oct 19, 2023
HepaSphere Transarterial Chemoembolization Combined With Hepatic
Not yet recruiting
- Colorectal Liver Metastases (CRCLM)
- DEB-TACE plus HAIC
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
May 25, 2023